VOR (VOR) Stock Price & Analysis
VOR (VOR) rose 3.34% to USD 25.05 as of September 8, 2026 at 06:56 UTC, according to Nexqual real-time market data.
VOR last closed at USD 25.05; the session ranged USD 24.02–25.17 on volume of 421,763 shares. Market capitalization is —, with a 52-week range of USD 6.5–49.95 (NMS). Source: Nexqual, September 8, 2026 at 06:56 UTC.
Key Statistics (as of September 8, 2026 at 06:56 UTC)
| Price | USD 25.05 |
|---|---|
| Change | ▲ 3.34% (up) |
| Previous Close | USD 25.05 |
| Open | USD 25.05 |
| Day Range | USD 24.02 – 25.17 |
| 52-Week Range | USD 6.5 – 49.95 |
| Volume | 421,763 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VOR)
Nexqual's technical model rates VOR "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:56 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 64.25 (neutral) |
| vs SMA50 | Above (USD 21.19) |
| MACD | 0.87 (positive) |
From VOR's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMCR | Immunocore Holdings plc | USD 36.13 | ▼ 3.32% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
| BCAB | BioAtla, Inc. | USD 1.74 | ▲ 43.98% |
| SANA | Sana Biotechnology, Inc. | USD 3.85 | ▼ 1.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:56 UTC. This page is informational and not investment advice.